Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
about
New combinations in the treatment of COPD: rationale for aclidinium-formoterolSpecific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseEffects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease.Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?
P2860
Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aclidinium bromide/formoterol ...... for COPD: the evidence to date
@en
type
label
Aclidinium bromide/formoterol ...... for COPD: the evidence to date
@en
prefLabel
Aclidinium bromide/formoterol ...... for COPD: the evidence to date
@en
P2860
P921
P356
P1476
Aclidinium bromide/formoterol ...... for COPD: the evidence to date
@en
P2093
Arvind B Bhome
Bill B Brashier
P2860
P304
P356
10.2147/DDDT.S53150
P407
P577
2015-04-07T00:00:00Z